1. Home
  2. EEFT vs SRPT Comparison

EEFT vs SRPT Comparison

Compare EEFT & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EEFT

Euronet Worldwide Inc.

HOLD

Current Price

$67.50

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$16.70

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EEFT
SRPT
Founded
1994
1980
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.5B
IPO Year
1996
2000

Fundamental Metrics

Financial Performance
Metric
EEFT
SRPT
Price
$67.50
$16.70
Analyst Decision
Buy
Hold
Analyst Count
5
29
Target Price
$95.00
$25.85
AVG Volume (30 Days)
698.3K
2.8M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
6.05
N/A
EPS
0.83
2.88
Revenue
$4,244,200,000.00
$2,198,237,000.00
Revenue This Year
$8.17
N/A
Revenue Next Year
$5.97
N/A
P/E Ratio
$77.60
$5.99
Revenue Growth
6.38
15.58
52 Week Low
$62.50
$10.42
52 Week High
$107.91
$25.32

Technical Indicators

Market Signals
Indicator
EEFT
SRPT
Relative Strength Index (RSI) 48.90 47.97
Support Level $64.79 $16.37
Resistance Level $75.49 $18.16
Average True Range (ATR) 2.59 0.76
MACD -0.07 0.31
Stochastic Oscillator 47.62 61.15

Price Performance

Historical Comparison
EEFT
SRPT

About EEFT Euronet Worldwide Inc.

Euronet Worldwide Inc is a provider of electronic financial transaction solutions. It offers payment and transaction processing and distribution solutions to financial institutions, retailers, service providers, and individual consumers. The company's product offerings include comprehensive ATM, POS, card outsourcing, card issuing, and merchant acquiring services, software solutions, money transfer services, etc. Its reportable operating segments are EFT Processing, epay, and Money Transfer. Maximum revenue is derived from its Money Transfer segment, which provides money transfer services across the world under the brand names Ria, AFEX, IME, and xe. Geographically, the company generates maximum revenue from the United States, followed by Germany, India, France, Greece, and other regions.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: